Hypophoshatemia Incidence in Patients with Chronic Kidney Disease Treated with Intravenous Ferric Carboxymaltose and Factors Related to Hypophosphatemia

Journal Title: The Medical Bulletin of Haseki - Year 2020, Vol 58, Issue 4

Abstract

Aim: We aimed to find the incidence of hypophoshatemia and to investigate predictive factors for the development of hypophospahtemia in patients with chronic kidney disease (CKD) treated with intravenous ferric carboxymaltose (FCM). Methods: In our single center retrospective study, we included 43 adult patients who were given FCM therapy after nephrology clinic admission. Thirty-three non-dialysis CKD patients constituded the CKD group. Control group consisted of 11 patients with the diagnosis of iron deficiency anemia and normal renal function. Patients with missing data on serum phosphorus level before and after treatment were excluded. Results: The average age of CKD group was 68.8±10.2 years (69% female). The average serum creatinin level and and estimated glomerular filtration rate were 2.3±1.1 mg/dL and 29.7±17.6 mL/min/1.73m2, respectively. After the first week following FCM treatment, five of 11 patients in the control group (44.5%) and three of 32 patients in the CKD group (9.4%) developed hypophosphatemia (p=0.008). On linear regression analysis, it was found that baseline phosphorus level was the single predictor of hypophosphatemia (p=0.006). Conclusion: Our study demonstrated that the incidence of hypophosphatemia associated with FCM treatment in CKD patients was compatible with the rates in the literature. Clinicians should be careful in FCM treatment especially in patients having low baseline phosphorus level.

Authors and Affiliations

Abdullah Şumnu, Ali Erdem Dal

Keywords

Related Articles

Does Carotid Atherosclerosis Cause Tinnitus?

Aim: Atherosclerosis is a disease affecting the intimas of arteries. We aimed to investigate the presence of carotid atherosclerosis in patients with tinnitus as an etiologic factor of tinnitus. Methods: A total of 73 p...

Neck Dissection in Early-stage Squamous Cell Carcinoma of the Lower Lip: Mid-term Treatment Results

Aim: To evaluate the mid-term treatment results in early-stage squamous cell carcinoma (SCC) of the lower lip and to investigate the effect of tumor depth and size on neck metastasis. Methods: The study included 52 pati...

Is Focused Parathyroidectomy Effective in Primary Hyperparathyroidism?

Aim: Primary hyperparathyroidism is an endocrine disease characterised by hypercalcemia due to increased parathormone (PTH) secretion. Treatment is surgical excision of pathologic glands by bilateral exploration of the p...

Hypophoshatemia Incidence in Patients with Chronic Kidney Disease Treated with Intravenous Ferric Carboxymaltose and Factors Related to Hypophosphatemia

Aim: We aimed to find the incidence of hypophoshatemia and to investigate predictive factors for the development of hypophospahtemia in patients with chronic kidney disease (CKD) treated with intravenous ferric carboxyma...

The Relationship Between Serum Vaspin Levels and the Degree of Coronary Involvement in Patients with Stable Angina Pectoris

Aim: Vaspin is an insulin-sensitive adipokine secreted from visceral fat tissue, and belongs to the serine protease inhibitor family. The relationship between vaspin level and coronary artery disease is not known yet. We...

Download PDF file
  • EP ID EP688702
  • DOI 10.4274/haseki.galenos.2020.5947
  • Views 118
  • Downloads 0

How To Cite

Abdullah Şumnu, Ali Erdem Dal (2020). Hypophoshatemia Incidence in Patients with Chronic Kidney Disease Treated with Intravenous Ferric Carboxymaltose and Factors Related to Hypophosphatemia. The Medical Bulletin of Haseki, 58(4), -. https://europub.co.uk/articles/-A-688702